HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmaceutical Production of Anti-tumor and Immune-potentiating Enterococcus faecalis-2001 β-glucans: Enhanced Activity of Macrophage and Lymphocytes in Tumor-implanted Mice.

AbstractBACKGROUND:
Enterococcus faecalis 2001 is a probiotic lactic acid bacterium and has been used as a biological response modifier (BRM). From physiological limitation of bacterial preservation in storage and safety, the live E. faecalis 2001 has been heat-treated and the BRM components containing high level of β-glucan, named EF-2001, were prepared.
METHOD:
The heat-treated EF-2001 has been examined for the antioxidative potential for radical scavenging and anti-tumor activities as well as immune-enhancing response in mice. Lymphocyte versus polymorphonuclear leukocyte ratio was increased in mice upon treatment with EF-2001. The number of lymphocytes was increased in the EF-2001-treated group. In the mice bearing two different Ehrlich solid and Sarcoma-180 carcinomas, the treatment with EF-2001 resulted in anti-tumor action. Tumor-suppressive capacity upon treatment with EF-2001 was significantly increased compared to normal controls.
RESULTS:
During the time interval administration of 5 weeks between the priming and secondary administration of EF-2001, the expression and production levels of TNF-α were also observed in the EF- 2001-administered mice. Additionally, anti-tumor activity examined with the intravenous administration of EF 2001 with a 34 times interval was also observed, as the growth of Sarcoma180 cells was clearly inhibited by the EF-2001.
CONCLUSION:
From the results, it was suggested that the immune response is enhanced due to antioxidative activity caused by the EF-2001 and anti-tumor activity by NK cells and TNF-α.
AuthorsYeun-Hwa Gu, Hyunju Choi, Takenori Yamashita, Ki-Mun Kang, Masahiro Iwasa, Moon-Jo Lee, Kyoung Hae Lee, Cheorl-Ho Kim
JournalCurrent pharmaceutical biotechnology (Curr Pharm Biotechnol) Vol. 18 Issue 8 Pg. 653-661 (Nov 10 2017) ISSN: 1873-4316 [Electronic] Netherlands
PMID28969561 (Publication Type: Journal Article)
CopyrightCopyright© Bentham Science Publishers; For any queries, please email at [email protected].
Chemical References
  • Antineoplastic Agents
  • Antioxidants
  • Immunologic Factors
  • Tumor Necrosis Factor-alpha
  • beta-Glucans
Topics
  • Animals
  • Antineoplastic Agents (isolation & purification, pharmacology)
  • Antioxidants (isolation & purification, pharmacology)
  • Carcinoma, Ehrlich Tumor (drug therapy, immunology)
  • Enterococcus faecalis
  • Immunologic Factors (isolation & purification, pharmacology)
  • Killer Cells, Natural (drug effects)
  • Lymphocytes (drug effects, immunology)
  • Macrophages (drug effects, immunology)
  • Male
  • Mice, Inbred ICR
  • Neutrophils (drug effects, immunology)
  • Probiotics
  • Sarcoma 180 (drug therapy, immunology)
  • Tumor Necrosis Factor-alpha (analysis)
  • beta-Glucans (isolation & purification, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: